Close

No products in your cart

Continue shopping

The Roadmap Series IV: Mapping BAM vs. BAD - Understanding the Nuances

30th April 2025 | You ask and we deliver! Following our Roadmap on the importance of bile acids as signalling molecules, many of you asked if Tanya could cover Bile Acid Malabsorption (BAM) and Bile Acid Diarrhoea (BAD). 

As April is IBS Awareness Month, join us for an illuminating exploration of Bile Acid Malabsorption (BAM) and Bile Acid Diarrhoea (BAD) – commonly confused terms with important clinical distinctions.

This Roadmap webinar will clarify how these conditions differ in terminology and pathophysiology while sharing practical insights for improved client outcomes.

You'll discover:

  • The crucial difference between BAM as a pathophysiological mechanism and BAD as a clinical syndrome
  • The three distinct pathophysiological pathways: primary, secondary, and associated conditions
  • How understanding these nuances can transform your diagnostic approach and treatment selection

Join live on Wednesday 30th April at 12:00 pm (BST) | Register here